ANI Pharmaceuticals | ANIP - 売上総利益

株価
74.67
毎日の変更
-0.15 -0.20%
毎月
-0.57%
毎年
16.20%
Q1 予測
72.43




売上総利益 変化する 日付
AbbVie USD 10.47B 605M 2025-09
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Assertio Holdings USD 22.24M 970K 2024-06
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Canopy Growth CAD 21.47M 434K 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Heron Therapeutics USD 29.47M 3.17M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Nektar Therapeutics USD 13.75M 650K 2024-06
Novartis USD 10.82B 694M 2025-09
Omeros USD -33.16M 18.52M 2024-06
Perrigo USD 362.2M 14.9M 2025-12
Sun Pharmaceuticals INR 107.66B 2.05B 2025-09
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12